Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 15:14:1473-1485.
doi: 10.2147/JIR.S302391. eCollection 2021.

Histone Deacetylase 6 Regulates the Activation of M1 Macrophages by the Glycolytic Pathway During Acute Liver Failure

Yao Wang #  1 , Xun Li #  1 , Qian Chen  1 , Fangzhou Jiao  1 , Chunxia Shi  1 , Maohua Pei  1 , Luwen Wang  1 , Zuojiong Gong  1
Affiliations

Histone Deacetylase 6 Regulates the Activation of M1 Macrophages by the Glycolytic Pathway During Acute Liver Failure

Yao Wang et al. J Inflamm Res. .

Abstract

Background: The glycolysis pathway of M1 macrophages is a key factor affecting the inflammatory response. The aim of this article is to investigate the role of histone deacetylase 6 (HDAC6) in the M1 macrophage glycolysis pathway during acute liver failure (ALF).

Methodology: Targeted metabolomics for quantitative analysis of energy metabolites technology was used to detect the characteristics of energy metabolism for 8 ALF patients and 8 normal volunteers. The ALF mice model was intervened with HDAC6 inhibitor ACY-1215. iTRAQ/TMT quantitative proteomics was used to detect protein expression in livers in different mice groups. The liver function, energy metabolites, M1 macrophages, cytokines, and pathological structure, DDX3X, NLRP3 and DNMT1 in liver tissue were detected. The changes of the above molecules were verified in cell groups.

Results: ALF patients and mice have significant energy metabolism disorders, accompanied by activation of M1 macrophages. After the intervention of ACY-1215, the activated M1 macrophages and cytokines levels in the mouse liver were reduced. The levels of IDH1, MDH1, and ATP were significantly increased. The expression of DDX3X increased, while the expression of NLRP3 and DNMT1 decreased. ACY-1215 could reduce the model cell apoptosis level and inflammatory response, and improve energy metabolism. It could also promote the expression of DDX3X, and inhibit the expression of NLRP3 and DNMT1.

Conclusion: ACY-1215 could inhibit the activation of M1 macrophages by improving the glycolytic pathway through regulating DNMT1 and DDX3X/NLRP3 signals to alleviate ALF.

Keywords: HDAC6; M1 macrophage; acute liver failure; metabolic reprogramming.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest for this work.

Figures

Figure 1
Figure 1
(A) Characteristics of energy metabolism for ALF patients. (B) The expression levels of L-Lactate, L-Malate, Isocitrate, Succinate, 3-phosphoglycerate, ADP, α-Ketoglutarate, ATP, Citrate, Oxaloacetate, NAD, NADPH, Phosphoenolpyruvate, and UDPglucose were significantly different between ALF patients and normal volunteers. (C) Based on the Pearson correlation analysis method, the correlation coefficient between different metabolites was calculated. The correlation between the different metabolites was displayed in the form of a correlation coefficient matrix heat map, and the expression of each metabolite was replaced by the ratio of the relative expression of the ALF group to the relative expression of the normal group. This matrix chart shows the correlation between significantly different metabolites. The Pearson correlation coefficient value R was between −1 and +1. The correlation coefficient R between metabolites was represented by color and circle, where R > 0 represents a positive correlation, and it was represented by red. R < 0 indicates a negative correlation, which was represented by blue. The larger and darker the circles, the more relevant they were. It was found that the expression for α-Ketoglutarate, Citrate, and Oxaloacetate was positively correlated with ATP. The expression for L-Malate, Isocitrate, and Succinate was negatively correlated with ATP. (D) Hypothesis diagram of M1 macrophage energy metabolism during ALF process.
Figure 2
Figure 2
The effect of ACY-1215 on LPS/D-Gal induced ALF mice. (A) HE staining was used to detect histopathological changes in liver. TUNEL staining was used to detect the cell apoptosis level. The serum levels of ALT, AST, and TBIL were detected. (B) Venn diagram showing the protein quantitative sequencing. (A) ACY-1215 intervention group. M: Model group. N: Control group. M/N (up/down) represented the protein whose expression level was increased (decreased) in the model group compared with the normal group. A/M (up/down) represented the protein whose expression level was increased (decreased) in the ACY-1215 intervention group compared with the model group. The table showed different expression levels of MDH1, IDH1 and DNMT1 in different mice groups. (C) The substrate and product of MDH1 were L-Malate and Oxaloacetate. The substrate and product of IDH1 were Isocitrate and α-Ketoglutarate. (D) The levels of ATP, Oxaloacetate, MDH1, α-Ketoglutarate, Citrate, MDH1, L-Malate, Isocitrate and Succinate in liver were tested. Data are shown as mean ± SD. #P < 0.05, compared with the control group. *P < 0.05, compared with the LPS/D-Gal group.
Figure 3
Figure 3
The effect of ACY-1215 on Acetyl-DNMT1, DDX3X/NLRP3 pathway and cytokines in ALF mice. (A) The level of HDAC6 and DNMT1 was detected by immunofluorescence. (B) The level of NLRP3 and DDX3X was detected by immunofluorescence. Data are shown as mean ± SD. #P < 0.05, compared with control group. *P < 0.05, compared with LPS/D-Gal group.
Figure 4
Figure 4
The effect of ACY-1215 on cytokines and marker proteins of M1 macrophages in ALF mice. (A–D) The levels of HIF1α, TNF-α, IL-6, and IL-1β were tested by ELISA kits. (E) The levels of iNOS and CD68 were detected by immunofluorescence. Data are shown as mean ± SD. #P < 0.05, compared with the control group. *P < 0.05, compared with the LPS/D-Gal group.
Figure 5
Figure 5
The effect of ACY-1215 on energy metabolite in LPS induced RAW264.7 cells. (A) The levels of ATP, Oxaloacetate, MDH1, α-Ketoglutarate, Citrate, MDH1, L-Malate, Isocitrate, and Succinate in RAW264.7 cells was tested. (B–D) The levels of DDX3X, NLRP3, and DNMT1 were detected by immunofluorescence. (E) A histogram was used to show the protein level of DDX3X, NLRP3 and DNMT1. (F) Cell apoptosis was detected by flow cytometry. (G) The levels of HIF1α, TNF-α, IL-6, and IL-1β in cell were tested by ELISA kits. Data are shown as mean ± SD. #P < 0.05, compared with the control group. *P < 0.05, compared with the LPS group.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bernal W, Wendon J. Acute Liver Failure. N Engl J Med. 2013;369(26):2525–2534. - PubMed
    1. McPhail MJ, Kriese S, Heneghan MA. Current management of acute liver failure. Curr Opin Gastroenterol. 2015;31(3):209–214. doi:10.1097/MOG.0000000000000174 - DOI - PubMed
    1. Takaya H, Yoshiji H, Kawaratani H, et al. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure. Biomed Rep. 2017;7(3):277–285. doi:10.3892/br.2017.945 - DOI - PMC - PubMed
    1. Wang LK, Wang LW, Li X, et al. Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure. Hepatobiliary Pancreat Dis Int. 2013;12(2):180–188. doi:10.1016/s1499-3872(13)60029-6 - DOI - PubMed
    1. Woodhouse CA, Patel VC, Singanayagam A, et al. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Aliment Pharmacol Ther. 2018;47(2):192–202. doi:10.1111/apt.14397 - DOI - PubMed